Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Nicole Massoll

Concepts (210)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thyroid Nodule
5
2022
32
1.050
Why?
Thyroid Neoplasms
8
2022
113
1.030
Why?
Biopsy, Fine-Needle
7
2024
104
0.560
Why?
Uterus
2
2008
81
0.480
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2008
62
0.480
Why?
Papillomavirus Infections
2
2008
177
0.420
Why?
Carcinoma, Papillary
3
2017
50
0.420
Why?
Breast Neoplasms
6
2018
1223
0.350
Why?
Vulvar Neoplasms
3
2008
61
0.320
Why?
Carcinoma, Squamous Cell
4
2008
332
0.320
Why?
Cysts
2
2006
53
0.300
Why?
MicroRNAs
3
2022
397
0.290
Why?
Uterine Cervical Neoplasms
2
2008
301
0.270
Why?
Uterine Cervical Dysplasia
1
2008
51
0.260
Why?
Precancerous Conditions
1
2008
87
0.260
Why?
Carcinoma, Lobular
1
2007
32
0.250
Why?
Cytological Techniques
1
2006
13
0.240
Why?
Carcinoma, Ductal, Breast
1
2007
89
0.240
Why?
Adenomyoma
1
2005
2
0.230
Why?
Neoplasms, Hormone-Dependent
1
2005
8
0.230
Why?
Carcinoma in Situ
2
2008
72
0.230
Why?
Biopsy, Needle
1
2006
181
0.220
Why?
Lymph Nodes
3
2017
252
0.220
Why?
Gynecologic Surgical Procedures
1
2005
29
0.220
Why?
Focal Adhesion Protein-Tyrosine Kinases
3
2010
17
0.220
Why?
Uterine Neoplasms
1
2005
57
0.220
Why?
Competency-Based Education
1
2024
31
0.210
Why?
Carcinoma, Medullary
1
2004
12
0.210
Why?
Fellowships and Scholarships
1
2024
124
0.190
Why?
Mastectomy
2
2018
147
0.190
Why?
Humans
31
2024
53246
0.190
Why?
Clinical Competence
1
2024
406
0.170
Why?
Pathology
3
2024
37
0.170
Why?
Focal Adhesion Kinase 1
2
2012
14
0.160
Why?
Diagnosis, Differential
4
2008
1038
0.160
Why?
Diagnostic Tests, Routine
1
2020
31
0.160
Why?
Female
20
2020
28792
0.160
Why?
Carcinoma, Neuroendocrine
1
2020
27
0.160
Why?
Mutation
6
2022
1338
0.160
Why?
DNA, Neoplasm
2
2018
146
0.150
Why?
Lung Neoplasms
2
2015
645
0.150
Why?
Proto-Oncogene Proteins B-raf
2
2017
78
0.140
Why?
Protein Kinase Inhibitors
2
2012
234
0.140
Why?
Immunohistochemistry
6
2015
975
0.140
Why?
Thyroid Gland
3
2020
76
0.130
Why?
Pancreatic Neoplasms
2
2010
219
0.130
Why?
Gene Silencing
2
2008
122
0.120
Why?
Neoplasm Invasiveness
5
2015
281
0.120
Why?
Middle Aged
10
2020
13422
0.120
Why?
DNA, Viral
2
2008
136
0.120
Why?
PTEN Phosphohydrolase
1
2016
55
0.120
Why?
Pulmonary Medicine
1
2015
15
0.110
Why?
Fibroblasts
2
2016
363
0.110
Why?
Cytodiagnosis
1
2015
42
0.110
Why?
Cell Proliferation
4
2016
1031
0.110
Why?
Sensitivity and Specificity
3
2020
869
0.110
Why?
Endosonography
1
2015
98
0.110
Why?
Lymphatic Metastasis
3
2017
211
0.100
Why?
Adult
9
2020
14541
0.100
Why?
Aged, 80 and over
5
2020
3495
0.100
Why?
Receptor, erbB-2
2
2018
79
0.100
Why?
Laryngeal Diseases
1
2013
12
0.090
Why?
Laryngectomy
1
2013
27
0.090
Why?
Herpes Simplex
1
2013
25
0.090
Why?
Purine Nucleosides
1
2012
3
0.090
Why?
Receptor, IGF Type 1
1
2012
21
0.090
Why?
Immunoenzyme Techniques
2
2008
134
0.080
Why?
Predictive Value of Tests
2
2020
933
0.080
Why?
Receptors, Somatomedin
1
2010
8
0.080
Why?
Vascular Endothelial Growth Factor Receptor-3
1
2009
8
0.080
Why?
Tissue Fixation
2
2020
35
0.070
Why?
Melanoma
1
2012
277
0.070
Why?
Aniline Compounds
1
2009
48
0.070
Why?
Retrospective Studies
5
2022
6821
0.070
Why?
Fluorescent Antibody Technique, Direct
1
2008
3
0.070
Why?
Cell Movement
1
2009
279
0.070
Why?
Neuroblastoma
1
2008
55
0.070
Why?
Transglutaminases
1
2008
14
0.070
Why?
Aged
5
2020
10430
0.070
Why?
Biopsy
2
2007
600
0.070
Why?
Mastitis
1
2007
3
0.070
Why?
Genetic Markers
1
2008
104
0.070
Why?
GTP-Binding Proteins
1
2008
85
0.070
Why?
Genes, erbB-2
1
2007
8
0.060
Why?
Prednisone
1
2007
101
0.060
Why?
Granuloma
1
2007
46
0.060
Why?
Gene Expression Regulation, Enzymologic
1
2008
180
0.060
Why?
Group Practice
1
2006
3
0.060
Why?
Cystatins
1
2006
1
0.060
Why?
Cadherins
1
2007
62
0.060
Why?
Genomic Instability
1
2007
88
0.060
Why?
Frozen Sections
1
2006
13
0.060
Why?
Colonic Neoplasms
1
2008
162
0.060
Why?
Specialization
1
2006
48
0.060
Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2008
579
0.060
Why?
Tumor Suppressor Protein p53
1
2008
228
0.060
Why?
Medicine
1
2006
51
0.060
Why?
Promoter Regions, Genetic
1
2008
465
0.060
Why?
RNA, Small Interfering
3
2012
214
0.060
Why?
Gene Expression
1
2008
618
0.060
Why?
Antigens, CD
1
2007
217
0.060
Why?
Mullerian Ducts
1
2005
4
0.060
Why?
Medical Oncology
1
2006
97
0.060
Why?
Fallopian Tubes
1
2005
22
0.060
Why?
Estrogen Replacement Therapy
1
2005
28
0.060
Why?
Signal Transduction
1
2012
1748
0.060
Why?
Chromosome Aberrations
1
2007
297
0.060
Why?
Glucocorticoids
1
2007
236
0.060
Why?
Data Collection
1
2006
288
0.060
Why?
ABO Blood-Group System
1
2005
16
0.060
Why?
Vulva
1
2005
18
0.060
Why?
Ovariectomy
1
2005
114
0.060
Why?
Hysterectomy
1
2005
91
0.060
Why?
Mice, Nude
3
2010
232
0.050
Why?
Decision Making
1
2007
278
0.050
Why?
Regression Analysis
1
2006
391
0.050
Why?
Epithelial Cells
1
2006
218
0.050
Why?
Carcinoma, Transitional Cell
1
2005
54
0.050
Why?
Papillomaviridae
1
2005
104
0.050
Why?
Cell Survival
3
2012
600
0.050
Why?
Epigenesis, Genetic
1
2008
412
0.050
Why?
Cell Line, Tumor
4
2009
1470
0.050
Why?
Mice
5
2017
5982
0.050
Why?
Cohort Studies
2
2020
1557
0.050
Why?
Ultrasonography
1
2006
426
0.050
Why?
Polymerase Chain Reaction
1
2005
452
0.050
Why?
Male
6
2020
27444
0.050
Why?
Prospective Studies
2
2022
2412
0.050
Why?
Base Sequence
3
2010
620
0.050
Why?
Education, Medical, Graduate
1
2024
219
0.050
Why?
Gene Expression Profiling
1
2007
1112
0.040
Why?
Formaldehyde
1
2020
51
0.040
Why?
Oncogenes
1
2020
61
0.040
Why?
Adolescent
2
2015
6912
0.040
Why?
Neoplasm Staging
2
2015
774
0.040
Why?
Transplantation, Heterologous
2
2010
78
0.040
Why?
Antineoplastic Agents
1
2008
1232
0.040
Why?
Animals
5
2017
13528
0.040
Why?
Blotting, Western
2
2012
587
0.040
Why?
DNA Primers
2
2010
202
0.040
Why?
Young Adult
2
2020
4514
0.030
Why?
Paraffin Embedding
1
2018
52
0.030
Why?
Receptors, Progesterone
1
2018
68
0.030
Why?
Specimen Handling
1
2018
63
0.030
Why?
Receptors, Estrogen
1
2018
134
0.030
Why?
Methylene Blue
1
2017
7
0.030
Why?
Lymphatic System
1
2017
13
0.030
Why?
Animals, Genetically Modified
1
2017
54
0.030
Why?
Coloring Agents
1
2017
65
0.030
Why?
Mice, Inbred Strains
1
2017
163
0.030
Why?
Prognosis
2
2015
2118
0.030
Why?
Follow-Up Studies
2
2015
2318
0.030
Why?
Treatment Outcome
1
2006
5597
0.030
Why?
Apoptosis
2
2012
1139
0.030
Why?
Cost Savings
1
2015
60
0.030
Why?
Neoplasm Grading
1
2015
128
0.030
Why?
RNA, Messenger
2
2008
1133
0.030
Why?
Collagen
1
2016
215
0.030
Why?
Cost-Benefit Analysis
1
2015
274
0.030
Why?
Disease Progression
2
2008
880
0.030
Why?
Tumor Microenvironment
1
2016
274
0.020
Why?
DNA Methylation
2
2008
592
0.020
Why?
Immunoprecipitation
1
2012
56
0.020
Why?
In Situ Nick-End Labeling
1
2012
54
0.020
Why?
Flow Cytometry
1
2012
400
0.020
Why?
Cell Line
1
2012
1016
0.020
Why?
Staurosporine
1
2009
10
0.020
Why?
Deoxycytidine
1
2009
26
0.020
Why?
Drug Synergism
1
2009
147
0.020
Why?
Cell Adhesion
1
2009
163
0.020
Why?
RNA Interference
1
2009
181
0.020
Why?
Xenograft Model Antitumor Assays
1
2009
228
0.020
Why?
Polymorphism, Single-Stranded Conformational
1
2008
18
0.020
Why?
Luciferases
1
2008
50
0.020
Why?
Chromatin Immunoprecipitation
1
2008
48
0.020
Why?
Adenoviridae
1
2008
46
0.020
Why?
Florida
1
2008
70
0.020
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2008
68
0.020
Why?
Fluorouracil
1
2008
59
0.020
Why?
Loss of Heterozygosity
1
2008
78
0.020
Why?
Phosphorylation
1
2009
533
0.020
Why?
Electrophoresis, Polyacrylamide Gel
1
2008
93
0.020
Why?
Transcriptional Activation
1
2008
128
0.020
Why?
Estrogens
1
2009
224
0.020
Why?
Drug Screening Assays, Antitumor
1
2008
136
0.020
Why?
Transfection
1
2008
359
0.020
Why?
Enzyme Inhibitors
1
2009
371
0.020
Why?
Ultrasonography, Mammary
1
2007
61
0.020
Why?
Kaplan-Meier Estimate
1
2008
487
0.020
Why?
Molecular Sequence Data
1
2008
759
0.020
Why?
Transcription, Genetic
1
2008
374
0.020
Why?
Cystatin M
1
2006
17
0.020
Why?
5' Untranslated Regions
1
2006
29
0.020
Why?
RNA, Neoplasm
1
2006
45
0.020
Why?
Cesarean Section
1
2007
158
0.010
Why?
Survival Rate
1
2008
949
0.010
Why?
Mice, Knockout
1
2008
910
0.010
Why?
Gene Expression Regulation, Neoplastic
1
2009
868
0.010
Why?
Cells, Cultured
1
2008
1569
0.010
Why?
Chi-Square Distribution
1
2005
291
0.010
Why?
Neoplasm Recurrence, Local
1
2008
647
0.010
Why?
Pregnancy Complications
1
2007
406
0.010
Why?
Tomography, X-Ray Computed
1
2007
1183
0.010
Why?
Infant, Newborn
1
2008
2913
0.010
Why?
Magnetic Resonance Imaging
1
2007
1587
0.010
Why?
Pregnancy
1
2007
2610
0.010
Why?
Infant
1
2008
3808
0.010
Why?
Child, Preschool
1
2008
4164
0.010
Why?
Risk Factors
1
2008
4018
0.010
Why?
Child
1
2008
7384
0.010
Why?
Massoll's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description